Solventum (SOLV) Cash from Financing Activities (2023 - 2026)
Solventum (SOLV) posted Cash from Financing Activities of -$50.0 million for Q1 2026, up 56.52% on a QoQ basis from -$115.0 million in Q4 2025, and up 64.03% year-over-year from -$30.5 million in Q1 2025.
Solventum (SOLV) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Solventum's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at -$50.0 million for Q1 2026.
- Quarterly Cash from Financing Activities rose 64.03% year-over-year to -$50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 billion (down 252.91% YoY) and the FY2025 annual result came in at -$3.1 billion, down 1173.75% from the prior year.
- Cash from Financing Activities was -$50.0 million for Q1 2026 at Solventum, up from -$115.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $462.0 million in Q1 2024 and bottomed at -$2.7 billion in Q3 2025.
- A 4-year average of -$376.8 million and a median of -$202.0 million in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 200.0% — and 2025, when it sank 1233.17%.
- Solventum's Cash from Financing Activities stood at -$306.0 million in 2023, then jumped by 66.01% to -$104.0 million in 2024, then decreased by 10.58% to -$115.0 million in 2025, then jumped by 56.52% to -$50.0 million in 2026.
- Business Quant data shows SOLV's Cash from Financing Activities at -$50.0 million in Q1 2026, -$115.0 million in Q4 2025, and -$2.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.00 Mn |
| Mar 31, 2026 | -50.00 Mn |
| Dec 31, 2025 | -115.00 Mn |
| Dec 31, 2025 | -115.00 Mn |
| Sep 30, 2025 | -2.69 Bn |
| Sep 30, 2025 | -2.69 Bn |
| Jun 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -139.00 Mn |
| Mar 31, 2025 | -139.00 Mn |
| Dec 31, 2024 | -104.00 Mn |
| Dec 31, 2024 | -104.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Mar 31, 2024 | 462.00 Mn |
| Mar 31, 2024 | 462.00 Mn |
| Dec 31, 2023 | -306.00 Mn |
| Dec 31, 2023 | -306.00 Mn |